Designing new enzymes that use light to create pharmaceuticals
Computational Framework for the Mechanistic Studies and Physics-Informed Prediction and Design of Photoenzymes
This study is looking at a new way to design special enzymes that can be turned on by light to help make complex medicines more easily and efficiently, which could be really helpful for people who need hard-to-make drugs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northeastern University NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10940408 on NIH RePORTER |
What this research studies
This research focuses on developing a new approach to enzyme design that utilizes light to activate certain enzymes, known as photoenzymes, for creating complex pharmaceuticals. By integrating computational tools, the researchers aim to understand how light, specific cofactors, and protein sequences influence the reactivity of these enzymes. This could lead to more efficient and innovative methods for synthesizing drugs that are difficult to produce using traditional methods. The study will explore the mechanisms behind these reactions to create a systematic design strategy for future applications.
Who could benefit from this research
Good fit: Patients who may benefit from this research include those requiring complex medications that are currently difficult to produce.
Not a fit: Patients with conditions that do not require novel pharmaceutical synthesis may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and efficient methods for synthesizing important pharmaceuticals.
How similar studies have performed: While the concept of using light in enzyme design is emerging, this specific approach to photoenzymes is relatively novel and has not been extensively tested in prior research.
Where this research is happening
Boston, United States
- Northeastern University — Boston, United States (Active)
Researchers
- Principal investigator: Dong, Sijia — Northeastern University
- Study coordinator: Dong, Sijia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.